Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Allergan
Allergan
Page 4 of 6
Finance
Pfizer Says No Merger Tax Help For Our Top Execs
By
Financial Writer
November 25, 2015
Leadership
Pfizer’s CEO Isn’t a Hero or a Villain
By
Senior Editor
November 25, 2015
Finance
Pfizer’s Allergan Deal is an Even Bigger Tax Dodge Than It’s Claiming
By
Digital Assets Editor
November 24, 2015
Finance
Investors Aren’t Convinced the Pfizer-Allergan Deal is a Go
By
Market Analyst
November 23, 2015
Finance
Will the Pfizer Inversion Get It Booted From the Dow?
By
News Correspondent
November 23, 2015
Finance
Pfizer/Allergan deal pushes 2015 into the record books
By
Contributing Writer
November 23, 2015
Health
Prediction: Healthcare’s M&A Flood Will Ebb in 2016
By
Staff Writer
November 23, 2015
Health
Pfizer, Allergan Confirm $160 Billion Merger Deal
By
Geoffrey Smith
and
Claire Groden
November 23, 2015
Leadership
Pfizer, Allergan Poised for $150 Billion Merger
By
Staff Writer
November 22, 2015
Finance
Why New Tax Inversion Rules Won’t Stop Pfizer-Allergan Deal
By
News Correspondent
November 20, 2015
Leadership
Will Lobbying Dollars Put Pfizer and Allergan On The Fast Track?
By
Contributing Writer
November 20, 2015
Finance
Why Pfizer Is Headed for Splitsville After Allergan Merger
By
Market Analyst
November 19, 2015
Leadership
A Pfizer Deal With Allergan Would Add Fuel to the Fight Over Taxes
By
Crypto Correspondent
November 19, 2015
Finance
Why Mylan Just Lost The Largest Hostile Takeover Battle Ever
By
Trading Desk
November 13, 2015
Health
Valeant, Ackman Must Face U.S. Insider Trading Lawsuit
By
Digital Assets Editor
November 11, 2015
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Senior Editor
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Digital Assets Editor
Economy
Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
By
Blockchain Reporter